ABSTRACT
Purpose: The coronavirus disease 19 (COVID?19) pandemic has resulted in a huge impact on the health care system. Diversion of health care workforce toward management of a high number of COVID?19 cases and lockdown restrictions have affected the follow?up of patients. The objective of this study was to analyze the impact of this situation on the control of diabetes, eventually resulting in related neuro?ophthalmological complications. Methods: This retrospective case series included diabetic patients visiting the neuro?ophthalmology clinic at a tertiary care eye center in India from 25 March 2020 to 25 September 2020 during the lockdown. The incidence of diabetes?related neuro?ophthalmological complications, including third, fourth, sixth nerve palsies and non?arteritic anterior ischemic optic neuropathy (NAION) was evaluated and compared with that of the same period during 2019. Results: Overall disease incidence rate was significantly higher in the year 2020 (60.2%) compared to the previous year of 2019 (29.8%). The proportion of third nerve palsy (4.8% vs 16.3%, P < 0.001) and NAION (0.3% vs 14.3%, P < 0.001) had increased. Even though the percentage of sixth nerve palsy was 25% in 2020, this was not significantly different from 2019. There was a reduction in the percentage of fourth nerve palsy cases from the year 2019 to 2020. Conclusion: There was a significant increase in diabetes?related neuro?ophthalmic complications during the COVID?19 lockdown. This can possibly be attributed to worsening of glycemic control in diabetic patients.